Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zai Lab LtdZLAB · Entity 4271 | CCO & President, Greater China | June 25, 2022 | June 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zai Lab Ltd
Report date June 25, 2022 · Filed June 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 31,300 |
Reported balance
After 2022-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-25 · Grant · Acquired 31,300 · Balance 31,300 F1: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer. F2: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
F2: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2022 Filed Jun 28, 2022 01:47 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 31,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-024346 · doc4.xml · derivative · entry 1 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,300 Underlying: American Depositary Shares · 31,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer. F2 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F2 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionRestricted Share Units · Derivative | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013697 · doc4.xml · derivative · entry 4 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,920 Underlying: American Depositary Shares · 730 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F7 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F7 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 7,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013697 · doc4.xml · derivative · entry 3 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,154 Underlying: American Depositary Shares · 7,154 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer. F6 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F6 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 37,585 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0000899243-22-013697 · doc4.xml · derivative · entry 2 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,585 Underlying: American Depositary Shares · 37,585 shares Expires 2032-04-01 F3 · shares: The Stock Options are exercisable for ADSs. The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer. F4 · derivative.exercise_date: The Stock Options vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. F1 · derivative.underlying: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:05 UTC | Zai Lab Ltd ZLAB · Entity 4271 | Exercise / conversionAmerican Depositary Shares | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-013697 · doc4.xml · nonDerivative · entry 1 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. F2 · shares: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 01:53 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantRestricted Share Units · Derivative | 3,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014994 · doc4.xml · derivative · entry 2 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,650 Underlying: Ordinary Shares · 3,650 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Ordinary Share of the issuer. F3 · derivative.exercise_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting. F3 · derivative.expiration_date: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 01:53 UTC | Zai Lab Ltd ZLAB · Entity 4271 | GrantStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $130.96 | $0.00 |
DisclosureSEC source: 0000899243-21-014994 · doc4.xml · derivative · entry 1 Liang Yi · CIK 0001835832 · CCO & President, Greater China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The Stock Options vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.